FDA Draft Guidance on Third Party Review Program: Scope and Definitions
The new article highlights the aspects related to the applicability scope, and also provides definitions of the key terms and concepts.
The new article highlights the aspects related to the applicability scope, and also provides definitions of the key terms and concepts.
The article provides a brief overview of the existing legal framework associated with the third-party review.
The new article covers some specific aspects associated with the evidential expectations for implantable devices, such as human factors, clinical performance testing, and labeling.
The article outlines the general considerations for evidentiary expectations and describes in detail the authority’s non-clinical recommendations.
The article highlights the key points associated with the concept of evidentiary expectations in the context of marketing submissions.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report